- Home
- HBIO vs GDTC Comparison
HBIO vs GDTC Comparison
Compare HBIO & GDTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HBIO
- GDTC
- Stock Information
- Founded
- HBIO 1901
- GDTC 2018
- Country
- HBIO United States
- GDTC Singapore
- Employees
- HBIO N/A
- GDTC N/A
- Industry
- HBIO Biotechnology: Laboratory Analytical Instruments
- GDTC Biotechnology: Pharmaceutical Preparations
- Sector
- HBIO Industrials
- GDTC Health Care
- Exchange
- HBIO Nasdaq
- GDTC Nasdaq
- Market Cap
- HBIO 24.6M
- GDTC 24.2M
- IPO Year
- HBIO 2000
- GDTC 2023
- Fundamental
- Price
- HBIO $0.52
- GDTC $2.20
- Analyst Decision
- HBIO Buy
- GDTC
- Analyst Count
- HBIO 3
- GDTC 0
- Target Price
- HBIO $2.50
- GDTC N/A
- AVG Volume (30 Days)
- HBIO 17.4M
- GDTC 205.5K
- Earning Date
- HBIO 11-06-2025
- GDTC 01-01-0001
- Dividend Yield
- HBIO N/A
- GDTC N/A
- EPS Growth
- HBIO N/A
- GDTC N/A
- EPS
- HBIO N/A
- GDTC N/A
- Revenue
- HBIO $88,750,000.00
- GDTC $573,193.00
- Revenue This Year
- HBIO N/A
- GDTC $5.37
- Revenue Next Year
- HBIO $7.02
- GDTC N/A
- P/E Ratio
- HBIO N/A
- GDTC N/A
- Revenue Growth
- HBIO N/A
- GDTC 63.03
- 52 Week Low
- HBIO $0.28
- GDTC $1.65
- 52 Week High
- HBIO $2.82
- GDTC $4.05
- Technical
- Relative Strength Index (RSI)
- HBIO 58.79
- GDTC 48.45
- Support Level
- HBIO $0.40
- GDTC $2.18
- Resistance Level
- HBIO $0.94
- GDTC $3.68
- Average True Range (ATR)
- HBIO 0.06
- GDTC 0.31
- MACD
- HBIO 0.02
- GDTC -0.04
- Stochastic Oscillator
- HBIO 24.68
- GDTC 14.45
About HBIO Harvard Bioscience Inc.
Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, specialized products and services that enable fundamental research, pharmaceutical and therapy discovery, bioproduction, and pre-clinical testing for drug development. Its primary focus is scientific instruments used to advance life sciences and research. With operations in North America, Europe and china it sells through a combination of direct and distribution channels to customers around the world. The product brands of the company include Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, and Panlab. The majority of its revenue comes from the United States.
About GDTC CytoMed Therapeutics Limited
CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The company's segment include: the business of innate immune cell-based immunotherapy, pluripotent stem cell-based therapy and undertaking the research and development of immune cell and stem cell-based therapy; and the business of processing and banking of cells including cord blood stem cells, research and development on cord blood derived cell-based therapy. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.